| Name | Title | Contact Details |
|---|
San Luis Valley HMO is a Alamosa, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Bid Prep is a Aliso Viejo, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Nomad Health is the first digital marketplace for healthcare jobs, efficiently connecting quality clinicians with rewarding career opportunities and taking the busywork out of finding clinical work. We are a well-funded Series C startup backed by First Round Capital, RRE Ventures, .406 Ventures, Polaris Partners, Icon Ventures, and Kevin Ryan (founder of MongoDB, Zola, Gilt, and DoubleClick). The U.S. healthcare system is experiencing a staffing crisis. Employers spend $20 billion per year recruiting clinicians to provide care for patients around the country. Nomad replaces antiquated staffing agencies with modern technology to efficiently source, qualify, and hire medical talent on demand. Clinicians find better jobs with higher pay. Employers fill roles faster with higher quality care. Nomad is a fast growing team of technologists, creators, and industry experts passionate about modernizing healthcare staffing so doctors and nurses can get back to the work they do best: caring for others.
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products. Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries. Zimmer`s 2009 sales were approximately $4.1 billion. The Company is supported by the efforts of approximately 8,500 employees worldwide.
FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet medical needs. FibroGen’s research team is committed to discovering novel therapies in areas of major unmet medical need. Our goal is to continue to provide pipeline candidates supported by rigorous data in well-characterized therapeutic settings. All of FibroGen`s therapeutic candidates have been internally developed based on FibroGen`s pioneering research in two important areas of biology, hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF).